MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 47 filers reported holding MILESTONE PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 61.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,932,044 | +8.9% | 2,558,724 | +0.1% | 0.00% | +100.0% |
| Q2 2023 | $7,282,568 | -27.6% | 2,555,287 | +0.1% | 0.00% | -50.0% |
| Q1 2023 | $10,056,712 | -4.1% | 2,552,465 | -3.6% | 0.00% | 0.0% |
| Q4 2022 | $10,482,579 | +991.9% | 2,647,116 | +2433.2% | 0.00% | – |
| Q3 2022 | $960,000 | +1197.3% | 104,497 | +770.5% | 0.00% | – |
| Q2 2022 | $74,000 | -3.9% | 12,004 | 0.0% | 0.00% | – |
| Q1 2022 | $77,000 | -2.5% | 12,004 | 0.0% | 0.00% | – |
| Q4 2021 | $79,000 | +14.5% | 12,004 | 0.0% | 0.00% | – |
| Q3 2021 | $69,000 | +4.5% | 12,004 | 0.0% | 0.00% | – |
| Q2 2021 | $66,000 | -5.7% | 12,004 | 0.0% | 0.00% | – |
| Q1 2021 | $70,000 | -53.0% | 12,004 | -46.0% | 0.00% | – |
| Q4 2020 | $149,000 | +69.3% | 22,250 | +85.4% | 0.00% | – |
| Q3 2020 | $88,000 | – | 12,004 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alta Fundamental Advisers LLC | 897,961 | $2,559,189 | 1.24% |
| VR Adviser, LLC | 2,208,812 | $6,295,114 | 1.01% |
| Bleichroeder LP | 1,326,085 | $3,779,342 | 0.77% |
| BML Capital Management, LLC | 272,500 | $776,625 | 0.70% |
| Lion Point Capital, LP | 450,207 | $1,283,090 | 0.58% |
| Affinity Asset Advisors, LLC | 300,068 | $855,194 | 0.30% |
| Ikarian Capital, LLC | 460,416 | $1,312,186 | 0.21% |
| PVG ASSET MANAGEMENT CORP | 15,405 | $43,904 | 0.19% |
| RTW INVESTMENTS, LP | 3,256,102 | $9,279,891 | 0.18% |
| Boxer Capital, LLC | 698,861 | $1,992 | 0.09% |